EV1 DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER)
2011 ◽
Vol 29
(15_suppl)
◽
pp. 6000-6000
2011 ◽
Vol 17
(9 Supp A)
◽
pp. S27-S33
◽
2014 ◽
Vol 3
(4)
◽
pp. 423-433
◽
2010 ◽
Vol 1
(1)
◽
pp. 83-88
◽